CSIMarket

Gilead Sciences Inc   (GILD)
Other Ticker:  
 
 

Gilead Sciences Inc Growth Comparisons

Select each growth Category to receive further Information



GILD Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 2.6% 25.35% 13.74% 14.08%
Q / Q Revenue Growth (Q1 MRQ) -9.03% -7.04% -0.25% -2.56%
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 7.46% 35.27% 20.29% %
Seq. Revenue Growth (for 12 months ending Q1 TTM) 0.61% 3.78% 2.95% 3.25%
Revenue 5 Year Average Growth -2.12% 10.69% 10.14% 12%


GILD's Growth Comparisons in the I. Quarter 2022




Gilead Sciences Inc 's Revenue slowed to the 2.6% year on year, improvement in the first quarter 2022 to 6.59 billions, underperforming the 25.35% improvement in the Biotechnology & Pharmaceuticals industry and 13.74% Revenue improvement in the Healthcare sector. Comparing the first quarter, sales Gilead Sciences Inc was trailing overall market not just Biotechnology & Pharmaceuticals industry.

Top-line fell by -9.03% from the forth quarter. Average annual sales growth for Gilead Sciences Inc is -2.12%, while S & P 500's average yearly sales increase is 12%, including only Businesses with the first quarter 2022 financial results.


Growth Rates of GILD's Income in the first quarter 2022


GILD Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) -93.18% -21.22% 0.44% 11.53%
Seq. Operating Income Change (Q1 MRQ) -79.04% -38.49% -12.35% -10.23%
Y / Y Operating Income Growth (Q1 TTM) 58.48% 92.33% 77.54% 64.25%
Seq. Operating Income Growth (Q1 TTM) -27.15% -0.45% 1.14% 3.11%
Operating Income 5 Year Avg. Change -10.87% -0.66% 9.96% 17.24%


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) -99.3% -10.9% -27.09% 3.43%
Seq. Income from Cont. Ops. Change (Q1 MRQ) -96.81% -44.27% -41.22% -7.43%
Y / Y Income from Cont. Ops. Change (Q1 TTM) 1545.05% 319.84% 119.2% 69.21%
Seq. Income from Cont. Ops. Change (Q1 TTM) -27.58% 0.12% -4.86% 1.03%
Income from Cont. Ops. 5 Year Avg. Change -14.39% 5.04% 19.24% 20.07%

GILD Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) -99.3% -10.91% -27.75% 4.97%
Q / Q Net Income Growth (Q1 MRQ) -96.81% -42.05% -40.88% -6.48%
Y / Y Net Income Change (Q1 TTM) 1545.05% 310.44% 126.93% 73.41%
Seq. Net Income Change (Q1 TTM) -27.58% 0.51% -4.93% 1.35%
Net Income 5 Year Avg. Growth -14.39% 4.89% 19.49% 20.27%

GILD's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) -98.55% -22.72% -27.09% 3.43%
Seq. EPS from Cont. Ops. Change (Q1 MRQ) -93.42% -23.88% -41.22% -7.43%
Y / Y EPS from Cont. Ops. Change (Q1 TTM) 1367.66% - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) -27.45% - - 8247.51%
EPS from Cont. Ops. 5 Year Avg. Growth -13.22% NAN% 19.24% 20.07%



GILD EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) -98.54% -22.73% -27.75% 20.07%
Q / Q EPS Net Growth (Q1 MRQ) -93.38% -20.85% -40.88% -6.48%
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 60375.49%
Seq. EPS Net Change (for 12 months ending Q1 TTM) -27.37% - - 55.46%
EPS Net 5 Year Avg. Change -13.09% 4.89% 19.49% 20.27%
Expected EPS Growth (Y/Y) - - 123.59% 20.77%



As Gilead Sciences Inc 's income per share faded by -98.54% year on year in the first quarter, Biotechnology & Pharmaceuticals industry fell only by -22.73%, Gilead Sciences Inc 's first quarter performance was trailing Biotechnology & Pharmaceuticals, and underperformed the -27.75% EPS slide in the Healthcare sector. Weak first quarter income per share, in Biotechnology & Pharmaceuticals industry and within the Healthcare sector, were reflected in Gilead Sciences Inc results which underperformed overall market.

Bottom-line fell by -93.38% from the forth quarter results. Comparing the annual growth, income per share of -13.09% on average in last five years, to the S & P 500's, including only Businesses with the first quarter 2022 earnings, average yearly income per share growth is 20.27%. Gilead Sciences Inc grew less than the market.

GILD Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) -29.5% -40.2% -15.55% 0.36%
Seq. Free Cash Flow Change (Q1 MRQ) -42.59% -42.73% -33.74% -64.62%
Y / Y Free Cash Flow Change (Q1 TTM) 13.62% 16.59% 11.67% 46.74%
Seq. Free Cash Flow Change (Q1 TTM) -6.76% -7.42% 0.41% -1.07%
Free Cash Flow 5 Year Avg. Change -7.46% 8.62% 19.27% 25.19%

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - -
Seq. Net Cash Flow Change (Q1 MRQ) - - - -
Y / Y Net Cash Flow Change (Q1 TTM) - - - -81.91%
Seq. Net Cash Flow Change (Q1 TTM) - - - -53.98%
Net Cash Flow 5 Year Avg. Change - - 50.34% 123.84%

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 49.7% 21.83% 6.35% 14.59%
Seq. Capital Expenditures Change (Q1 MRQ) 58.33% 5.3% -33.04% -38.7%
Y / Y Capital Expenditures Change (Q1 TTM) 2.64% 30.97% 11.76% 20.97%
Seq. Capital Expenditures Change (Q1 TTM) 14.16% 4.69% 2.79% 2.95%
Capital Expenditures 5 Year Avg. Change - 348.17% 159.14% 81.16%

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ALYA's Profile

Stock Price

ALYA's Financials

Business Description

Fundamentals

Charts & Quotes

ALYA's News

Suppliers

ALYA's Competitors

Customers & Markets

Economic Indicators

ALYA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071